ArticleIndian journal of pharmacology2026
Andrographolide inhibits hepatocellular carcinoma progression and programmed death ligand-1 expression by blocking STAT3 phosphorylation.
Hairong Fu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.